Drug Trial Radar · NCT06644781
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
510
Planned (sponsor's estimate)
Start
Mar 27, 2025
Primary completion
Jun 1, 2028
Study completion Nov 1, 2029
Sponsor
- Lead sponsor
- Daiichi SankyoDaiichi Sankyo (DSNKY)
- Sponsor type
- Industry
- Collaborators
- Merck Sharp & Dohme LLC
- First posted
- Oct 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd) in patients with unresectable advanced or metastatic esophageal squamous cell carcinoma (ESCC) who have experienced disease progression following treatment with a platinum-based systemic therapy and an immune checkpoint inhibitor (ICI) compared with investigator's choice of chemotherapy (ICC).
Conditions
- Esophageal Squamous Cell Carcinoma
Interventions
Ifinatamab deruxtecanDrug
Intravenous administration
DocetaxelDrug
Intravenous administration
PaclitaxelDrug
Intravenous administration
Irinotecan hydrochloride (HCl)Drug
Intravenous administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: From the date of randomization to the date of death due to any cause, up to approximately 54 months
Locations
168 sites in 17 countries. Site status is shown where the registry gives one.
Mayo Clinic Hospital
Phoenix, Arizona · Recruiting
Providence Medical Foundation
Fullerton, California · Recruiting
USC Norris Comprehensive Cancer Center
Los Angeles, California · Recruiting
Univ of California Irvine College of Medicine
Orange, California · Recruiting
Henry Ford Health System
Detroit, Michigan · Recruiting
Mayo Clinic Rochester
Rochester, Minnesota · Recruiting
MidAmerica Cancer Care - American Oncology Partners
Kansas City, Missouri · Recruiting
Morristown Medical Center
Morristown, New Jersey · Recruiting
Maimonides Cancer Center
Brooklyn, New York · Recruiting
Penn State University Milton S. Hershey Medical Center
Hershey, Pennsylvania · Recruiting
Baptist Cancer Center
Memphis, Tennessee · Recruiting
SCRI Oncology Partners
Nashville, Tennessee · Recruiting
John Peter Smith Hospital
Fort Worth, Texas · Recruiting
Virginia Cancer Specialists
Fairfax, Virginia · Recruiting
Institut Jules Bordet
Brussels, Belgium · Recruiting
Cliniques Universitaires Saint-Luc
Brussels, Belgium · Recruiting
Antwerp University Hospital
Edegem, Belgium · Recruiting
Universitair Ziekenhuis Gent
Ghent, Belgium · Recruiting
UZ Leuven
Leuven, Belgium · Recruiting
Chu de Liege
Liège, Belgium · Recruiting
Anyang Cancer Hospital
Anyang, China · Recruiting
Beijing Cancer Hospital
Beijing, China · Recruiting
Jilin Cancer Hospital
Changchun, China · Recruiting
The First Hospital of Jilin University
Changchun, China · Recruiting
Changzhou Cancer Hospital
Changzhou, China · Recruiting
Sichuan cancer hospital
Chengdu, China · Recruiting
West China Hospital Sichuan University
Chengdu, China · Recruiting
Fujian Cancer Hospital
Fuzhou, China · Recruiting
The First Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, China · Recruiting
Zhejiang Cancer Hospital
Hangzhou, China · Recruiting
Harbin Medical University Cancer Hospital
Harbin, China · Recruiting
Anhui Provincial Cancer Hospital
Hefei, China · Recruiting
The First Affiliated Hospital of Fujian Medical University
Hefei, China · Recruiting
The Second Hospital of Anhui Medical University
Hefei, China · Recruiting
Jieyang Peoples Hospital
Jieyang, China · Recruiting
Jinan Central Hospital
Jinan, China · Recruiting
Shandong Cancer Hospital
Jinan, China · Recruiting
Affiliated Hospital of Jining Medical University
Jining, China · Recruiting
Linyi Cancer Hospital
Linyi, China · Recruiting
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, China · Recruiting
Showing 40 of 168 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.